References
- Chan KF, Cheung KS, Ho CY, et al. Hong Kong's venomous land snakes. In: A Field Guide to the Venomous Land Snakes of Hong Kong: Agriculture, Fisheries and Conservation Department, Friends of the Country Parks and Cosmos Books Ltd; 2006.
- Fung HT, Lam KK, Kam CW. Efficacy and safety of snake antivenom therapy: experience of a regional hospital. Hong Kong J Emerg Med. 2006;13:70–78.
- WHO/SEARO Guidelines for the clinical management of snake bites in the Southeast Asian region [Internet]. [cited 2007 Apr 25]. Available from: http://apps.searo.who.int/PDS_DOCS/B4508.pdf
- Ng W, Cheung WL. Snake bites in Hong Kong: a prospective study on epidemiology and pre-hospital management. Hong Kong J Emerg Med. 1997;4:68–73.
- Hutton RA, Looareesuwan S, Ho M, et al. Arboreal green pit vipers (genus Trimeresurus) of South-East Asia: bites by T. albolabris and T. macrops in Thailand and a review of the literature. Trans R Soc Trop Med Hyg. 1990;84:866–874.
- Rojnuckarin P, Mahasandana S, Intragumthornchai T, et al. Prognostic factors of green pit viper bites. Am J Trop Med Hyg. 1998;58:22–25.
- Thiansookon A, Rojnuckarin P. Low incidence of early reactions to horse-derived F(ab')(2) antivenom for snakebites in Thailand. Acta Trop. 2008;105:203–205.
- Lavonas EJ. Antivenoms for snakebite: design, function, and controversies. Curr Pharm Biotechnol. 2012;13:1980–1986.
- Dart RC, McNally J. Efficacy, safety, and use of snake antivenoms in the United States. Ann Emerg Med. 2001;37:181–188.
- Agkistrodon halys bite treated with specific antivenin: discussion on 665 cases (author's transl). Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]. 1980;18:568–569. [Article in Chinese]
- Hsu YL, Wu CJ, Chou TC, et al. Retrospection and prospection for manufacturing of snake antivenins in Taiwan. Taiwan Epidemiol Bull. 2013;29:50–56.
- Chen JC, Bullard MJ, Chiu TF, et al. Risk of immediate effects from F(ab)2 bivalent antivenin in Taiwan. Wilderness Environ Med. 2000;11:163–167.
- Caron EJ, Manock SR, Maudlin J, et al. Apparent marked reduction in early antivenom reactions compared to historical controls: was it prophylaxis or method of administration? Toxicon. 2009;54:779–783.
- Amin MR, Mamun SMH, Rashid R, et al. Anti-snake venom: use and adverse reaction in a snake bite study clinic in Bangladesh. J Venom Anim Toxins incl Trop Dis. 2008;14:660–672.
- Gawarammana IB, Kularatne SA, Dissanayake WP, et al. Parallel infusion of hydrocortisone +/− chlorpheniramine bolus injection to prevent acute adverse reactions to antivenom for snakebites. Med J Aust. 2004;180:20–23.
- Williams DJ, Jensen SD, Nimorakiotakis B, et al. Antivenom use, premedication and early adverse reactions in the management of snake bites in rural Papua New Guinea. Toxicon. 2007;49:780–792.
- de Silva HA, Pathmeswaran A, Ranasinha CD, et al. Low-dose adrenaline, promethazine, and hydrocortisone in the prevention of acute adverse reactions to antivenom following snakebite: a randomised, double-blind, placebo-controlled trial. PLoS Med. 2011;8:e1000435.
- Fan HW, Marcopito LF, Cardoso JL, et al. Sequential randomised and double blind trial of promethazine prophylaxis against early anaphylactic reactions to antivenom for bothrops snake bites. BMJ. 1999;318:1451–1452.
- LoVecchio F, Klemens J, Roundy EB, et al. Serum sickness following administration of Antivenin (Crotalidae) Polyvalent in 181 cases of presumed rattlesnake envenomation. Wilderness Environ Med. 2003;14:220–221.
- Ryan NM, Kearney RT, Brown SG, et al. Incidence of serum sickness after the administration of Australian snake antivenom (ASP-22). Clin Toxicol. 2016;54:27–33.
- Lavonas EJ, Kokko J, Schaeffer TH, et al. Short-term outcomes after Fab antivenom therapy for severe crotaline snakebite. Ann Emerg Med. 2011;57:128–137.e3.
- de Silva HA, Ryan NM, de Silva HJ. Adverse reactions to snake antivenom, and their prevention and treatment. Br J Clin Pharmacol. 2016;81:446–452.
- Lawley TJ, Bielory L, Gascon P, et al. A study of human serum sickness. J Invest Dermatol. 1985;85:129s–132s.